Galactosemia future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Galactosemia}} {{CMG}} {{PleaseHelp}} ==Overview== ==Future or Investigational Therapies== ==References== {{Reflist|2}} {{WH}} {{WS}} Category:Needs conten..." |
|||
| Line 8: | Line 8: | ||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
The [[therapeutic]] modalities currently being explored are: | |||
===[[Aldose]] [[reductase]] [[inhibitors]]===<ref name="pmid2516529">{{cite journal| author=Lou MF, Dickerson JE, Chandler ML, Brazzell RK, York BM| title=The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576. | journal=J Ocul Pharmacol | year= 1989 | volume= 5 | issue= 3 | pages= 233-40 | pmid=2516529 | doi=10.1089/jop.1989.5.233 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2516529 }} </ref>: | |||
==References== | ==References== | ||
Revision as of 09:30, 5 July 2022
|
Galactosemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Galactosemia future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Galactosemia future or investigational therapies |
|
Galactosemia future or investigational therapies in the news |
|
Risk calculators and risk factors for Galactosemia future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Future or Investigational Therapies
The therapeutic modalities currently being explored are: ===Aldose reductase inhibitors===[1]:
References
- ↑ Lou MF, Dickerson JE, Chandler ML, Brazzell RK, York BM (1989). "The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576". J Ocul Pharmacol. 5 (3): 233–40. doi:10.1089/jop.1989.5.233. PMID 2516529.